Most microbiota studies in oncology have focused on recipients of allogeneic hematopoietic cell transplantation. By demonstrating similar microbiota assemblages in recipients of allogeneic hematopoie…
There is mounting evidence to support the use of ruxolitinib earlier in the disease course of myelofibrosis. Use in intermediate-1 risk myelofibrosis is generally associated…
Androgen-deprivation therapy (ADT) remains a cornerstone in treatment for patients with advanced prostate cancer and is associated with several adverse effects. Population-based assessment revealed t…
In this analysis from the Childhood Cancer Survivor Study, carotid ultrasound was underused, even among those with a history of radiation therapy to the neck.…
In this study of early-phase clinical trial participants, more than one third report financial toxicity. Financial toxicity was associated with lower quality of life, impaired…
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
The authors compared the ability of MB PSA, PSA doubling time, and PSA velocity in assessing future risk of lethal prostate cancer. Their findings failed…
Chemotherapy-induced peripheral neuropathy is a common and dose-limiting chemotoxicity caused by oxaliplatin. In this cohort analysis nested within a randomized controlled trial of 132 colon…
Cancer survivors who returned to work experienced a high and persisting risk of sick leave and disability pension for more than a decade. This may…
Comparison of patients in the ACA DCE-eligible age range (excluding ages and calendar years when patients with cancer would not have been eligible for DCE…
The objective of this study was to determine the association between the visceral adiposity index and both incident cancer across 23 sites and overall cancer…
